(Q45156541)

10 December 2017

Changes in brain size in hepatic encephalopathy: a coregistered MRI study (English)

1 reference

10 December 2017

hepatic encephalopathy

1 reference

1 reference

Simon D Taylor-Robinson

5

object named as

Simon D Taylor-Robinson

1 reference

10 December 2017

Nayna Patel

1

1 reference

10 December 2017

Susan White

2

1 reference

10 December 2017

Novraj S Dhanjal

3

1 reference

10 December 2017

Angela Oatridge

4

1 reference

10 December 2017

1 December 2004

1 reference

10 December 2017

Metabolic Brain Disease

1 reference

10 December 2017

19

1 reference

10 December 2017

3-4

1 reference

10 December 2017

431-445

1 reference

https://scigraph.springernature.com/pub.10.1023/b:mebr.0000043987.09022.e3

10 December 2017

0 references

cites work

Maintenance of cell volume in the central nervous system

1 reference

12 December 2020

Acute changes in cerebral blood flow and metabolism during portasystemic shunting.

1 reference

12 December 2020

Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy

1 reference

12 December 2020

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

1 reference

12 December 2020

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations

1 reference

12 December 2020

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

1 reference

12 December 2020

The Revised Kendrick Battery: Clinical studies

1 reference

12 December 2020

Brain lesions in alcoholics.

1 reference

12 December 2020

MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.

1 reference

12 December 2020

Brain swelling in first hour after coronary artery bypass surgery.

1 reference

12 December 2020

What the clinician can learn from MR glutamine/glutamate assays

1 reference

12 December 2020

Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia.

1 reference

12 December 2020

Changes in brain size with treatment in patients with hyper- or hypothyroidism.

1 reference

12 December 2020

Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant

1 reference

12 December 2020

Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols

1 reference

12 December 2020

The role of cellular hydration in the regulation of cell function

1 reference

12 December 2020

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

12 December 2020

MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status

1 reference

12 December 2020

Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy

1 reference

12 December 2020

Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis.

1 reference

12 December 2020

Change in brain size during and after pregnancy: study in healthy women and women with preeclampsia

1 reference

12 December 2020

Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy

1 reference

12 December 2020

Transection of the oesophagus for bleeding oesophageal varices

1 reference

12 December 2020

Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging

1 reference

12 December 2020

Major complications of acute and chronic liver disease.

1 reference

12 December 2020

Brain edema in liver failure: basic physiologic principles and management

1 reference

12 December 2020

Magnetic resonance image segmentation using pattern recognition, and applied to image registration and quantitation.

1 reference

12 December 2020

If you drink your brain will shrink. Neuropathological considerations

1 reference

12 December 2020

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

1 reference

12 December 2020

Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study

1 reference

12 December 2020

A registration and interpolation procedure for subvoxel matching of serially acquired MR images.

1 reference

12 December 2020

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

1 reference

12 December 2020

Brain atrophy in chronic alcoholic patients: a quantitative pathological study

1 reference

12 December 2020

Alcohol-induced brain damage and liver damage in young males

1 reference

12 December 2020

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study

1 reference

12 December 2020

1H magnetic resonance in the study of hepatic encephalopathy in humans

1 reference

12 December 2020

Review article: pathogenesis and treatment of chronic hepatic encephalopathy

1 reference

12 December 2020

Abnormal brain energy metabolism shown by in vivo phosphorus magnetic resonance spectroscopy in patients with chronic liver disease.

1 reference

12 December 2020

Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis

1 reference

12 December 2020

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial

1 reference

12 December 2020

10.1023/B:MEBR.0000043987.09022.E3

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference